Cargando…

The impact of dual bronchodilation on cardiovascular serious adverse events and mortality in COPD: a quantitative synthesis [Corrigendum]

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2018
Materias:	Corrigendum
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6219409/ https://www.ncbi.nlm.nih.gov/pubmed/30464442 http://dx.doi.org/10.2147/COPD.S192178

Ejemplares similares

The impact of dual bronchodilation on cardiovascular serious adverse events and mortality in COPD: a quantitative synthesis
por: Rogliani, Paola, et al.
Publicado: (2017)

Clinical Significance of Bronchodilator Responsiveness Evaluated by Forced Vital Capacity in COPD: SPIROMICS Cohort Analysis [Corrigendum]
Publicado: (2020)

When is dual bronchodilation indicated in COPD?
por: Thomas, Mike, et al.
Publicado: (2017)

The utility of inflammatory markers to predict readmissions and mortality in COPD cases with or without eosinophilia [Corrigendum]
Publicado: (2016)

The use of multiple respiratory inhalers requiring different inhalation techniques has an adverse effect on COPD outcomes [Corrigendum]
Publicado: (2019)

COPD management costs according to the frequency of COPD exacerbations in UK primary care [Corrigendum]
Publicado: (2014)

Future concepts in bronchodilation for COPD: dual- versus monotherapy
por: Singh, Dave, et al.
Publicado: (2021)

Prognostic Role of NT-proBNP for in-Hospital and 1-Year Mortality in Patients with Acute Exacerbations of COPD [Corrigendum]
Publicado: (2020)

Corrigendum to “Recommendations for Diagnosis and Management of Osteoporosis in COPD Men”
por: Mazokopakis, Elias E., et al.
Publicado: (2017)

Bronchodilators in COPD: Impact of β-agonists and anticholinergics on severe exacerbations and mortality
por: Salpeter, Shelley R
Publicado: (2007)

Bronchiectasis in COPD patients: more than a comorbidity? [Corrigendum]
Publicado: (2019)

Russian guidelines for the management of COPD: algorithm of pharmacologic treatment [Corrigendum]
Publicado: (2019)

Nasal high-flow in acute hypercapnic exacerbation of COPD [Corrigendum]
Publicado: (2019)

Repetitive Saliva Swallowing Test Predicts COPD Exacerbation [Corrigendum]
Publicado: (2021)

Patient-reported outcomes of dual bronchodilator fixed-dose combination versus bronchodilator monotherapy in individuals with COPD
por: Strange, Charlie, et al.
Publicado: (2019)

Which bronchodilator in COPD?
por: Russell, Richard, et al.
Publicado: (2007)

COPD: maximization of bronchodilation
por: Nardini, Stefano, et al.
Publicado: (2014)

Corrigendum: Low-density Lipoprotein Cholesterol/High-density Lipoprotein Cholesterol Ratio as Predictor of First Acute Myocardial Infarction and Major Adverse Cardiovascular Event after Intervention in Young Males
Publicado: (2018)

Comparative effectiveness of triple therapy versus dual bronchodilation in COPD
por: Voorham, Jaco, et al.
Publicado: (2019)

Bimatoprost ophthalmic solution 0.03% lowered intraocular pressure of normal-tension glaucoma with minimal adverse events. [Corrigendum]
Publicado: (2013)

Bimatoprost ophthalmic solution 0.03% lowered intraocular pressure of normal-tension glaucoma with minimal adverse events [Corrigendum]
Publicado: (2013)

Profile of glycopyrronium for once-daily treatment of moderate-to-severe COPD [Corrigendum]
Publicado: (2014)

Predicting frequent COPD exacerbations using primary care data [Corrigendum]
Publicado: (2018)

The Relationship Between Morning Symptoms and the Risk of Future Exacerbations in COPD [Corrigendum]
Publicado: (2021)

Image-Enhanced Bronchoscopic Evaluation of Bronchial Mucosal Microvasculature in COPD [Corrigendum]
Publicado: (2022)

Sinonasal Symptoms in COPD: Burden and Associations with Clinical Markers of Disease [Corrigendum]
Publicado: (2022)

Impact of bronchodilator therapy on exercise tolerance in COPD
por: Aguilaniu, B
Publicado: (2010)

Reduced Variability of Endurance Time in New Protocols for Exercise Tests in COPD [Corrigendum]
Publicado: (2021)

The Association Between Cognitive Functions and Psychological Factors in Patients with Severe COPD [Corrigendum]
Publicado: (2023)

Cost-Effectiveness of Dual Bronchodilator Indacaterol/Glycopyrronium for COPD Treatment in China
por: Gong, Shiyi, et al.
Publicado: (2021)

A Pooled Analysis of Mortality in Patients with COPD Receiving Dual Bronchodilation with and without Additional Inhaled Corticosteroid
por: Miravitlles, Marc, et al.
Publicado: (2022)

Adapting Inhaled Medication Practice in COPD and Asthma to Avoid Funding the Tobacco Industry [Corrigendum]
Publicado: (2021)

Bronchodilators use in patients with COPD
por: Dong, Yaa-Hui, et al.
Publicado: (2015)

Clinical Impact and Healthcare Resource Utilization Associated with Early versus Late COPD Diagnosis in Patients from UK CPRD Database [Corrigendum]
Publicado: (2020)

Impact of switching from triple therapy to dual bronchodilation in COPD: the DACCORD ‘real world’ study
por: Vogelmeier, Claus F., et al.
Publicado: (2022)

Therapeutic Success in Swiss COPD Patients Receiving Dual Bronchodilation Therapy as COPD Maintenance Treatment
por: Spielmanns, Marc, et al.
Publicado: (2022)

Serenity Integrated Mentoring and the High Intensity Network: A scheme that raises serious questions for practice and governance in UK psychiatry – CORRIGENDUM
por: House, Allan
Publicado: (2023)

Tiotropium/olodaterol versus tiotropium in Japanese patients with COPD: results from the DYNAGITO study [Corrigendum]
Publicado: (2018)

Health behaviors and their correlates among participants in the Continuing to Confront COPD International Patient Survey [Corrigendum]
Publicado: (2017)

Ultrafine particles in airways: a novel marker of COPD exacerbation risk and inflammatory status [Corrigendum]
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_2ntdffd2rlj3phkdlvh0ou7pgn